FDA Clears Path For Genta’s Genasense In Chronic Lymphocytic Leukemia
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency acknowledges complete response as an appropriate primary endpoint for study; needs confirmatory evidence.